本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

10.04
-0.1499-1.47%
成交量:161.72萬
成交額:1,642.13萬
市值:21.98億
市盈率:-7.10
高:10.32
開:10.21
低:10.03
收:10.19
52周最高:16.44
52周最低:6.23
股本:2.19億
流通股本:1.85億
量比:1.22
換手率:0.87%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
淨資產收益率:-72.99%
總資產收益率:-34.95%
市淨率:4.23
市盈率(LYR):-7.07

資料載入中...

2021/08/09

重要事件披露

8-K - Current report
2021/08/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/09

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/07/22

重要事件披露

8-K - Current report
2021/06/22

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report
2021/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report